IGFBP-6 has also been implicated in a wide variety of fibrotic diseases of the skin, heart, lung, kidney, and liver, and contributes to cancer stroma in the tumor microenvironment which is mediated at least partially by interactions with TGF- β [120,121]. Here, IGFBP6 is linked to cancer.